Cargando…

Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival

(1) Background: Cancer treatment, including chemotherapy, endocrine therapy, targeted therapy and radiotherapy, has been identified as an important independent risk factor for venous thromboembolism in cancer patients. The aim of the study was to evaluate the effect of adjuvant therapy on the coagul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wrzeszcz, Katarzyna, Rhone, Piotr, Kwiatkowska, Katarzyna, Ruszkowska-Ciastek, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222121/ https://www.ncbi.nlm.nih.gov/pubmed/37240751 http://dx.doi.org/10.3390/life13051106

Ejemplares similares

High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study
por: Kwiatkowska, Katarzyna, et al.
Publicado: (2022)

Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study
por: Wrzeszcz, Katarzyna, et al.
Publicado: (2022)

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

Complex Analysis of Endothelial Markers as Potential Prognostic Indicators in Luminal Invasive Breast Carcinoma Patients: Outcomes of a Six-Year Observational Study
por: Kwiatkowska, Katarzyna, et al.
Publicado: (2023)

Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
por: Rhone, Piotr, et al.
Publicado: (2019)

Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study
por: Ruszkowska-Ciastek, Barbara, et al.
Publicado: (2021)

Stromal Cell-Derived Factor 1α (SDF-1α) in Invasive Breast Cancer: Associations with Vasculo-Angiogenic Factors and Prognostic Significance
por: Zarychta, Elżbieta, et al.
Publicado: (2021)

Pre-Operative Combination of Normal BMI with Elevated YKL-40 and Leptin but Lower Adiponectin Level Is Linked to a Higher Risk of Breast Cancer Relapse: A Report of Four-Year Follow-Up Study
por: Bielawski, Kornel, et al.
Publicado: (2020)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

Determinants of hypofibrinolysis in patients with digestive tract cancer
por: Gronostaj, Katarzyna, et al.
Publicado: (2016)

Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes
por: Barbara, Ruszkowska-Ciastek, et al.
Publicado: (2020)

Significant Interactions between Adipokines and Vitamin D Combined with the Estimated Glomerular Filtration Rate: A Geriatric Case Study
por: Biercewicz, Monika, et al.
Publicado: (2023)

Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients
por: Rhone, Piotr, et al.
Publicado: (2018)

Development and application of global assays of hyper‐ and hypofibrinolysis
por: Ilich, Anton, et al.
Publicado: (2019)

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023)

Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View
por: Zarychta, Elżbieta, et al.
Publicado: (2022)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
por: Schrick, Diana, et al.
Publicado: (2021)

Dipyrimadole & Post-Operative Hypercoagulability
por: Jayaswal, U.
Publicado: (1967)

Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
por: Blasi, Annabel, et al.
Publicado: (2019)

Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy
por: Jarman, Michael Ian, et al.
Publicado: (2017)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
por: Bryk-Wiązania, Agata Hanna, et al.
Publicado: (2021)

Increased number of endothelial progenitor cells in the blood of patients with psoriasis vulgaris
por: Małkowska, Justyna, et al.
Publicado: (2021)

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
por: Meltzer, Mirjam E, et al.
Publicado: (2008)

Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland
por: Gagala, Jacek, et al.
Publicado: (2013)

Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model
por: Campos Nogueira, Yzabella Alves, et al.
Publicado: (2019)

A seven-gene signature predicts overall survival of patients with colorectal cancer
por: Chen, Huarong, et al.
Publicado: (2016)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Free flap thrombosis in patients with hypercoagulability: A systematic review
por: Biben, Johannes Albert, et al.
Publicado: (2019)

Gestational Diabetes Mellitus Worsens the Profile of Cardiometabolic Risk Markers and Decrease Indexes of Beta-Cell Function Independently of Insulin Resistance in Nondiabetic Women with a Parental History of Type 2 Diabetes
por: Sokup, Alina, et al.
Publicado: (2014)

Trends of Ordering Hypercoagulability Work-Up at an Academic Medical Center
por: Alidoost, Marjan, et al.
Publicado: (2021)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon, Stephan G, et al.
Publicado: (2016)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Identification of a seven-cell cycle signature predicting overall survival for gastric cancer
por: Zhang, Lian-Qun, et al.
Publicado: (2022)

Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study
por: Sokup, Alina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j42l9d174719lf5p1q4tgaaol2